Dr. Jake Sloane, a well-known facial aesthetic doctor and thought leader, will present “How to Successfully Introduce Rejuran into Your Clinic” at the 24th Dubai World Dermatology and Laser Conference & Exhibition (Dubai Derma 2025), taking place from April 14 to 16 at the Dubai World Trade Centre.
Rejuran is an injectable gel containing polynucleotides, designed for tissue restoration and reconstruction in the mid to deep dermis. As one of the practitioners involved in introducing Rejuran to the Australian market, Dr. Sloane will share insights on clinical applications, patient selection, consultation strategies, and best practices for incorporating Rejuran into clinical workflows.
Dr. Sloane’s session will explore how Rejuran has been integrated into aesthetic practices, including its role in tissue restoration. He will also provide guidance on clinical photography, patient communication strategies, and professional education surrounding Rejuran’s use.
About Dr Jake Sloane
Dr. Jake Sloane is from the UK and moved to Australia in 2015. He trained as a general surgeon in the UK and Australian for a decade before committing his time and passion to facial aesthetics. He has over 17 years experience and lectures around the world to share his insights. He is the co-founder and co-host of the “Inside Aesthetics” podcast, the world’s most listened to aesthetic podcast with nearly 300 published episodes to date.
Dr. Sloane is especially recognised for his dedication to medical education within the aesthetics community.
About Rejuran
Rejuran is an injectable gel listed in the Australian Register of Therapeutic Goods (ARTG) with an intended purpose of promoting tissue restoration and reconstruction in the mid to deep dermis, improving the physical appearance of the skin. It contains polynucleotides and utilizes DOTTM technology, which is being explored for its potential role in skin treatment.
About Dubai Derma
Dubai Derma is an annual event dedicated to dermatology, skincare, and laser advancements. The 24th edition will take place from April 14 to 16, 2025, at the Dubai World Trade Centre, bringing together industry experts, practitioners, and researchers to share the latest scientific and clinical insights.
